1208689007: Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...

\Medicinal product categorized by disposition\Product containing peroxisome proliferator-activated receptor agonist (product)\Product containing thiazolidinedione\Product containing pioglitazone\Product containing alogliptin and pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
\Medicinal product categorized by disposition\Product containing peroxisome proliferator-activated receptor agonist (product)\Product containing thiazolidinedione\Product containing pioglitazone\Product containing alogliptin and pioglitazone (medicinal product)\Product containing only alogliptin and pioglitazone (medicinal product)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
\Medicinal product categorized by disposition\Product containing peroxisome proliferator-activated receptor agonist (product)\Product containing thiazolidinedione\Product containing pioglitazone\Product containing pioglitazone in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
\Medicinal product categorized by disposition\Product containing peroxisome proliferator-activated gamma receptor agonist\Product containing thiazolidinedione\Product containing pioglitazone\Product containing alogliptin and pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
\Medicinal product categorized by disposition\Product containing peroxisome proliferator-activated gamma receptor agonist\Product containing thiazolidinedione\Product containing pioglitazone\Product containing alogliptin and pioglitazone (medicinal product)\Product containing only alogliptin and pioglitazone (medicinal product)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
\Medicinal product categorized by disposition\Product containing peroxisome proliferator-activated gamma receptor agonist\Product containing thiazolidinedione\Product containing pioglitazone\Product containing pioglitazone in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing peptide hydrolase inhibitor\Product containing dipeptidyl peptidase IV inhibitor\Product containing alogliptin\Product containing alogliptin and pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing peptide hydrolase inhibitor\Product containing dipeptidyl peptidase IV inhibitor\Product containing alogliptin\Product containing alogliptin and pioglitazone (medicinal product)\Product containing only alogliptin and pioglitazone (medicinal product)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing peptide hydrolase inhibitor\Product containing dipeptidyl peptidase IV inhibitor\Product containing alogliptin\Product containing alogliptin in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)

\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrimidine\Product containing alogliptin\Product containing alogliptin and pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrimidine\Product containing alogliptin\Product containing alogliptin and pioglitazone (medicinal product)\Product containing only alogliptin and pioglitazone (medicinal product)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing pyrimidine\Product containing alogliptin\Product containing alogliptin in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiazole\Product containing thiazolidinedione\Product containing pioglitazone\Product containing alogliptin and pioglitazone (medicinal product)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiazole\Product containing thiazolidinedione\Product containing pioglitazone\Product containing alogliptin and pioglitazone (medicinal product)\Product containing only alogliptin and pioglitazone (medicinal product)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiazole\Product containing thiazolidinedione\Product containing pioglitazone\Product containing pioglitazone in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)

\Product manufactured as oral dose form\Product containing pioglitazone in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)
\Product manufactured as oral dose form\Product containing alogliptin in oral dose form (medicinal product form)\Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)\Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Mar 2022. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

4970513016 Alogliptin and pioglitazone only product in oral dose form en Synonym Active Entire term case insensitive SNOMED CT core module
4970514010 Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)	Is a	Product containing only alogliptin and pioglitazone (medicinal product)	true	Inferred relationship	Existential restriction modifier
Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)	Is a	Product containing alogliptin and pioglitazone in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)	Has manufactured dose form	Oral dose form	true	Inferred relationship	Existential restriction modifier
Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)	Has active ingredient	Pioglitazone	true	Inferred relationship	Existential restriction modifier	1
Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)	Has active ingredient	Alogliptin	true	Inferred relationship	Existential restriction modifier	2

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug)	Is a	True	Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	Is a	True	Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	Is a	True	Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug)	Is a	True	Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug)	Is a	True	Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug)	Is a	True	Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
4970513016	Alogliptin and pioglitazone only product in oral dose form	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
4970514010	Product containing only alogliptin and pioglitazone in oral dose form (medicinal product form)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module